Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating MK-0646 with gemcitabine +/- erlotinib in advanced pancreatic cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating CO-1.01 as second-line therapy for gemcitabine-refractory metastatic pancreatic adenocarcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction [NA]
A completed clinical trial evaluating endoscopic ultrasound and endoscopic retrograde cholangiopancreatography for malignant distal biliary …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy [Phase 2]
The Phase 2 trial of luminespib (AUY922) in metastatic pancreatic cancer resistant to first-line chemotherapy was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis [NA]
A trial comparing EUS-guided radiofrequency ablation versus EUS-guided celiac plexus neurolysis for pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Phase 2]
Phase 2 trial evaluating metformin plus gemcitabine as adjuvant therapy after curative resection for pancreatic adenocarcinoma (stages IA–II…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Phase 2]
Phase 2 trial evaluating nab-paclitaxel combined with gemcitabine as adjuvant therapy after curative resection for pancreatic adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery [Phase 2]
Phase 2 trial investigating Cetuximab-IRDye 800CW for intraoperative imaging to locate pancreatic cancer during surgery; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
This trial update reports changes in circulating blood biomarkers over time in patients with pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for tosedostat with capecitabine in metastatic pancreatic adenocarcinoma (Phase 1/2); study terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update evaluating sequential AG and modified Folfirinox in metastatic pancreatic adenocarcinoma; phase 1/2 with unknown statu…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma [Phase 2]
Phase 2 trial evaluating L-asparaginase encapsulated in red blood cells in combination with gemcitabine or FOLFOX for second-line metastatic…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study [Phase 2]
Phase II study evaluating preoperative FOLFIRINOX for resectable pancreatic cancer was terminated; results posted in 2018.
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Incidence of POPF in the Resection of the Left Pancreas With RFAT
Clinical trial update evaluating the incidence of postoperative pancreatic fistula after resection of the left pancreas using RFAT; the tria…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma [NA]
The clinical trial evaluating PET/MRI in patients with pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating administration as a biological adjuvant in clinically-staged, resectable pancreatic adenocarcinoma has com…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer [Phase 2]
Phase 2 neoadjuvant treatment for pancreatic adenocarcinoma with efficacy and safety results reported.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Immunochemoradiotherapy in Patients With Pancreatic Cancer [Phase 1]
This entry notes the completion of a Phase 1 study evaluating immunochemoradiotherapy for locally advanced pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial update evaluating high- or standard-intensity radiation therapy after gemcitabine and nab-paclitaxel in unresectable pancreati…
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma [NA]
Clinical trial update on CAR-CLD18 T cells for advanced gastric adenocarcinoma and pancreatic adenocarcinoma; current trial status is unknow…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: FOLFIRINOX in Patients With Inoperable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating the FOLFIRINOX regimen in patients with inoperable pancreatic cancer has been terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Resilience and Exercise in Advanced Cancer Treatment [NA]
The clinical trial evaluating resilience and exercise in advanced cancer has completed, involving pancreatic adenocarcinoma, gastric adenoca…
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer [Phase 4]
A Phase 4 trial update evaluating gemcitabine plus nab-paclitaxel as secondary chemotherapy in advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 trial evaluating TH-302 in combination with gemcitabine for previously untreated metastatic or locally advanced unresectable pancr…
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Hyperthermia European Adjuvant Trial [Phase 3]
A Phase 3 European adjuvant trial evaluating hyperthermia for resected pancreatic adenocarcinoma; current status is not reported.